| Category: | PADi |
| Description: | Potent PAD4 inhibitor. It reduces tumor burden. |
| Synonyms: |
| 2D Image: |  |
| Structure 2D: | Download |
| Molecular Formula: | C27H29ClN4O2 |
| Molecular Weight: | 477.005 g/mol |
| IUPAC name: | N-[(2S)-5-[(1-amino-2-chloroethylidene)amino]-1-(benzylamino)-1-oxopentan-2-yl]-3-phenylbenzamide |
| InChI: | InChI=1S/C27H29ClN4O2/c28-18-25(29)30-16-8-15-24(27(34)31-19-20-9-3-1-4-10-20)32 -26(33)23-14-7-13-22(17-23)21-11-5-2-6-12-21/h1-7,9-14,17,24H,8,15-16,18-19H2,(H 2,29,30)(H,31,34)(H,32,33)/t24-/m0/s1 |
| SMILES: | C1=CC=C(C=C1)CNC(=O)C(CCCN=C(CCl)N)NC(=O)C2=CC=CC(=C2)C3=CC= CC=C3 |
| FDA status: | Experimental |
| FDA_UNII: | - |
| Clinical Trials : | Not recruiting Clinical Trials |
| No information available for YW4-03 |
| Literature Reference: | PMC3406678 |
| Literature: | Pubmed Google Scholar |
| PubChem ID: | 56970294 |
| PubChem Citation: | National Center for Biotechnology Information. PubChem Compound Database; CID=56970294, https://pubchem.ncbi.nlm.nih.gov/compound/56970294 (accessed Mar. 8, 2019). |
| ChEMBL ID: | CHEMBL3682417 |
| ZINC DB: | - |
| LiverTox: | Not available for YW4-03 |
| Human Metabolome database : | HMDB |